Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cistron Biotechnology(CIST)$.30 -- Ignore unavailable to you. Want to Upgrade?

To: John Metcalf who wrote (2163)	5/8/1999 2:56:00 PM
From: Steve Harmon	Respond to of 2742

I agree with you. No more silly business plans. Sell.

To: John Metcalf who wrote (2163)	5/8/1999 3:00:00 PM
From: Steve Harmon	Read Replies (1) \| Respond to of 2742

If you find out if Bruce G. gets to keep his 1.3 options if he is not employed with Cistron let me know.

To: John Metcalf who wrote (2163)	5/8/1999 3:14:00 PM
From: Steve Harmon	Respond to of 2742

And if he does lose them do you really think he would leave before he was able to cash in on those options? He has done wonders milking it so far. Would he leave without the cow>>aka the options? May 31 is his last day...

To: John Metcalf who wrote (2163)	5/8/1999 7:19:00 PM
From: scaram(o)uche	Read Replies (1) \| Respond to of 2742

>> because they concurred with the squandering of each opportunity. << Moreover, I believe that Edelman, if Galton ----> Smith ----> Harmon was ever a rational conduit, was a force behind at least one of the squanders. In any event, I got the impression that Galton was blaming Edelman for the periodontal brainstorm. But, you're correct..... there's not enough indignation among the Board, given the disaster that was created out of opportunity. >> What's left to work with? << Unless Naismith is "right up there with Galton", there should be tons of adjuvant-related stuff left to license. As I've discussed many times in this thread, one needs to target tumors and to "stealth" the IL-1. Sounds easier than it is, and, until you try it you won't know that the inflammation can be effective or controlled, but.... as far as I'm concerned, they've made next to zero effort in two years. Have they contacted VION, for example? I'm not convinced that a 100-fold reduction in lipid A is sufficient to make the Salmonella project (TAPET) a go, but.... heck, the VION story is a good fit. They just did a financing, and I'm certain that they'd have preferred to access what Galton left of CIST's cash. And, given Galton's animosity with shareholders, do we even know if he ever contacted companies like Vical? Hal Smith is a nice guy, but, given Galton's affection for me, it was like talking to a wall. You're very correct that I'm angry. I can usually just walk from a bad investment and shrug it off. This is one where I bear a grudge. Galton is, IMO, a low-life, slug's pr*ck. Is that clear? If not, I can try to put it in various other terms. Gladly.